federal_register: 94-9354

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
94-9354 Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment to Tentative Final Monograph; Reopening of Comment Period Uncategorized Document The Food and Drug Administration (FDA) is reopening to May 4, 1994, the comment period on the notice of proposed rulemaking pertaining to combinations of over-the-counter (OTC) internal analgesic and antacid ingredients, specifically sodium bicarbonate used as an antacid active ingredient (February 2, 1994, 59 FR 5068). FDA is taking this action in response to a request to extend the comment period for an additional 30 days to allow more time to comment on this proposal. The comment period for these issues closed on April 4, 1994. This proposal is part of the ongoing review of OTC drug products conducted by FDA. 1994-04-19 1994 4 https://www.federalregister.gov/documents/1994/04/19/94-9354/internal-analgesic-antipyretic-and-antirheumatic-drug-products-for-over-the-counter-human-use   Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA) is reopening to May 4, 1994, the comment period on the notice of proposed rulemaking pertaining to combinations of over-the-counter (OTC) internal analgesic and antacid ingredients, specifically sodium bicarbonate...

Links from other tables